Hepatectomy clinical trials

Explore recruiting hepatectomy clinical trials.

Recruiting hepatectomy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatectomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, transfusion requirement.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

PREDICTION OF COMPLICATIONS IN PATIENTS UNDERGOING SURGICAL TREATMENT OF HEPATIC TUMORS

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Intravenous lidocaine and post operative recovery after liver surgery – a randomized double blinded study

Sweden

Phase II and Phase III (Integrated) EU CTIS Study details

ILHEP : Effect of perioperative Intravenous Lidocaine on postoperative opioid related-side effects after open HEPatectomy: a multicentre prospective randomized controlled study

France

Therapeutic use (Phase IV) EU CTIS Study details

Double-blind, randomized, placebo-controlled, study to evaluate the safety and efficacy of HRX215 in participants after major hepatectomy, preceded by two open pilot parts in participants after minor and after major hepatectomy due to colon carcinoma metastases

France, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chemotherapy – PUMP IV trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatectomy trials by city

Hepatectomy in Toronto Hepatectomy in Vancouver Hepatectomy in Montreal Hepatectomy in Calgary Hepatectomy in Edmonton Hepatectomy in Ottawa Hepatectomy in Winnipeg Hepatectomy in Quebec City Hepatectomy in Hamilton Hepatectomy in Kitchener Hepatectomy in London Hepatectomy in Halifax Hepatectomy in New York Hepatectomy in Los Angeles Hepatectomy in Chicago Hepatectomy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease